Healthcare+ Expo 台灣醫療科技展
12月04日(四) 台灣醫療科技展 第一天
今天認識了很多新朋友～也有許多老朋友回來探望～
每次的展會，世延都能有些許的進步與與會來賓分享，
而這次非常開心能跟各位朋友分享我們2025年飛躍的進展～
我們會繼續堅持和努力，期待每次都能有好消息帶給各位朋友～
也請各位繼續支持世延生醫！
關於世延生醫：
世延生醫的口腔癌檢測試劑是使用唾液檢體，檢測唾液中的MMP-1蛋白質生物標誌，輔助判斷是否罹患口腔癌。
目前產品已經取得歐盟、新加坡、澳洲、香港、泰國、越南、菲律賓的醫材上市許可，
正在尋求國際市場合作，歡迎與我們聯繫並進一步討論～
Day 1 of the Taiwan Healthcare Expo
We met many new friends today—and welcomed back many familiar faces as well!
With every exhibition, S&T BioMed continues to grow, and we are truly excited to share our major advancements in 2025 with all of you. We will keep moving forward with dedication and passion, and we hope to bring good news every time we meet. Thank you all for your continued support for S&T BioMed!
About S&T BioMed:
Our oral cancer detection tests use saliva samples to measure the MMP-1 biomarker, providing an effective tool to assist in evaluating the risk of oral cancer.
Our products have already obtained medical device approvals in the EU, Singapore, Australia, Hong Kong, Thailand, Vietnam, and the Philippines.
We are actively seeking international partners—feel free to reach out to us for further collaboration!
